ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 909

Smoking Behavior Changes after Rheumatoid Arthritis Diagnosis and Risk of Mortality during 36 Years of Prospective Follow-up

Jeffrey A. Sparks1, Uyen Sa D.T. Nguyen2,3, Shun-Chiao Chang4,5, Yuqing Zhang6, Hyon Choi7 and Elizabeth W. Karlson4, 1Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Clinical Epidemiology Research &Training Unit, Boston University School of Medicine, Boston, MA, 3Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, 4Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 5Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 6Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 7Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: morbidity and mortality, Public Health Approach, rheumatoid arthritis (RA) and risk

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Epidemiology and Public Health I: RA Comorbidities and Mortality

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Smoking is a major preventable cause of death and cessation is recommended for the general population. However, it is unclear whether being diagnosis with RA affects smoking cessation and whether continuing to smoke contributes to the excess mortality of RA. We aimed to describe smoking behavior changes after RA diagnosis and to evaluate the effect of smoking on mortality after RA diagnosis.

Methods: We investigated smoking and mortality among women diagnosed with RA during follow-up in the Nurses’ Health Study (NHS). The NHS is composed of 121,700 women aged 30-55 years at baseline in 1976 and followed with biennial questionnaires. RA diagnosis was validated by medical record review according to the 1987 ACR criteria by two rheumatologists who identified the date of RA diagnosis. Smoking status and intensity (never, current, or past; cigarettes/day) were reported biennially during follow-up and cumulative smoking pack-years were calculated for each follow-up cycle. We categorized smoking at each follow-up cycle as occurring before or after the date of RA diagnosis. Deaths were identified by the National Death Index up to 2012. Cox regression models estimated HRs for all-cause mortality according to smoking pack-years after RA diagnosis, adjusting for sociodemographic, behavioral, and clinical factors.

Results: We analyzed 923 women diagnosed with RA during follow-up in the NHS with detailed prospective data available on smoking before and after RA diagnosis. There were 288 deaths in 16,111 person-years of follow-up. At RA diagnosis, mean age was 59.5 (SD 9.9) years, 52% were obese, and 60% consumed alcohol. In the cycle prior to RA diagnosis, 36% were never smokers, 43% were past smokers, and 21% were current smokers. Among current smokers just prior to RA diagnosis, 16% immediately quit smoking after RA diagnosis and maintained cessation, 21% continued to smoke throughout follow-up, 49% continued smoking for at least two cycles after RA but quit later, and 1% quit smoking after RA diagnosis then started smoking again later. Compared to never smokers after RA diagnosis, women who smoked >5 pack-years after RA diagnosis had significantly increased mortality (HR 2.69, 95% CI 1.33-5.46, Table) after adjustment for age, smoking pack-years prior to RA diagnosis, and other confounders. When analyzing only ever smokers at RA diagnosis, smoking >5 pack-years remained significantly associated with mortality compared to those who never smoked after RA diagnosis (HR 4.35, 95% CI 1.81-10.44).

Conclusion: Despite the known harmful effects of smoking in chronic diseases, only 16% of smokers quit after diagnosis with RA and maintained smoking cessation during follow-up. Smoking >5 pack-years after RA diagnosis was associated with increased mortality, independent of smoking before RA diagnosis. Interventions promoting cessation of smoking for patients newly diagnosed with RA may diminish the excess mortality of RA.

Table. Hazard ratios for all-cause mortality by cumulative smoking after RA diagnosis during 36 years of prospective follow-up in the Nurses’ Health Study, 1976-2012.

Cumulative smoking after RA diagnosis, N=923

Deaths/Person-years

Incidence (per 100,000)

Age and pre-RA smoking adjusted HR (95% CI)*

Multivariable HR (95% CI)**

Never/past/current smoker before RA and never smoker after RA diagnosis

184/12,307

1,529

1.00 (Ref)

1.00 (Ref)

>0-5 pack-years after RA diagnosis

44/2,070

2,126

1.49 (0.85-2.60)

1.42 (0.71-2.82)

>5 pack-years after RA diagnosis

60/1,734

3,460

2.98 (1.70-5.22)

2.69 (1.33-5.46)

 

Subgroup analysis: Cumulative smoking after RA diagnosis among ever smokers, N=590

Deaths/Person-years

Incidence (per 100,000)

Age and pre-RA smoking adjusted HR (95% CI)*

Multivariable HR (95% CI)**

Past/current smoker before RA and never smoker after RA diagnosis

113/6,172

1,831

1.00 (Ref)

1.00 (Ref)

>0-5 pack-years after RA diagnosis

44/2,070

2,126

1.50 (0.80-2.81)

1.68 (0.74-3.82)

>5 pack-years after RA diagnosis

60/1,734

3,460

3.88 (2.01-7.45)

4.35 (1.81-10.44)

*Adjusted for age, questionnaire period, and cumulative smoking prior to RA diagnosis (never, >0-10, >10-20, >20 pack-years)

**Additionally adjusted for median family income (<$40K, ≥$40K), body mass index category (underweight/normal, overweight, or obese), postmenopausal hormone (PMH) use (premenopausal or postmenopausal/never PMH use, postmenopausal/ever PMH use), physical activity (continuous METs-hours/week), alcohol consumption (0, >0-<5, ≥5 g/d), Alternate Healthy Eating Index without alcohol component (tertiles), cardiovascular disease, and aspirin use.


Disclosure: J. A. Sparks, None; U. S. D. T. Nguyen, None; S. C. Chang, None; Y. Zhang, None; H. Choi, None; E. W. Karlson, None.

To cite this abstract in AMA style:

Sparks JA, Nguyen USDT, Chang SC, Zhang Y, Choi H, Karlson EW. Smoking Behavior Changes after Rheumatoid Arthritis Diagnosis and Risk of Mortality during 36 Years of Prospective Follow-up [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/smoking-behavior-changes-after-rheumatoid-arthritis-diagnosis-and-risk-of-mortality-during-36-years-of-prospective-follow-up/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/smoking-behavior-changes-after-rheumatoid-arthritis-diagnosis-and-risk-of-mortality-during-36-years-of-prospective-follow-up/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology